The forecasting model projects that without major intervention, 1.8 billion people will have MASLD by 2050, and a ...

Lalan Wilfong, MD, a medical oncologist well-known for his work in practice transformation, said he looks forward to creating "something more or less from scratch." Lalan Wilfong, MD, one of the ...

Although the vast majority of physicians using an artificial intelligence (AI) scribe perceived a reduction in documentation time, those with the most actual time savings had higher relative baseline ...

Psychological effects of alopecia areata should be looked into in the future for patients who live with the condition.

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and ...

Telemedicine utilization has declined since the peak of the COVID-19 pandemic, but non–primary care specialties continue to see an increase in moderate- and high-complexity telemedicine visits.

Screening prevalence increased from 31.0% (45-49) to 64.2% (50-64) and 80.9% (65-75), but remained below optimal levels for ...

Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) and monotherapy subgroup (8.2% vs 11.1%). Transition to NYHA class IV was ...

A stringent ESR endpoint (week-4 PASI 100 with sustained PASI <1 through week 48) was met by 76.3%, reinforcing high real-world effectiveness of contemporary biologics. Biologic-naïve patients were ...

Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results ...